Lan Di-Hui, Zhang Yue, Hua Bing, Li Jin-Shui, He Yi, Chen Hui, Li Wei-Ping, Li Hong-Wei
Department of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
Diabetes Metab Syndr Obes. 2022 Jul 28;15:2207-2216. doi: 10.2147/DMSO.S369222. eCollection 2022.
Better survival for overweight and obese patients after ST-segment elevation myocardial infarction (STEMI) has been demonstrated. The association between body mass index (BMI), microvascular obstruction (MVO), and area at risk (AAR) after STEMI was evaluated.
A prospective observational study was performed to enrolled patients undergoing primary percutaneous coronary intervention (pPCI) for STEMI and cardiac magnetic resonance was performed within 5-7 days. Patients were classified as normal weight (18.5 ≤BMI <24.0 kg/m), overweight (24.0 ≤BMI <28.0 kg/m), or obese (BMI ≥28 kg/m).
Among 225 patients undergoing pPCI, 67 (30.00%) were normal weight, 113 (50.22%) were overweight, and 45 (20.00%) were obese. BMI ≥28 kg/m was significantly associated with less risk of MVO when compared with a normal BMI after multivariable adjustment (overweight: HR 0.29, 95% CI 0.13-0.68, p = 0.004). Compared with normal weight patients, obese and overweight patients tend to have larger hearts (greater left ventricular end-diastolic volume [LVEDV] and left ventricular [LV] mass). In adjusted analysis, increased BMI was significantly associated with a smaller AAR. In addition, obese patients had a smaller AAR (β = -0.252, 95% CI -20.298- -3.244, p = 0.007) and AAR, % LV mass (β = -0.331, 95% CI -0.211- -0.062, p < 0.001) than normal weight patients.
Obesity (BMI ≥28 kg/m) is independently associated with lower risks of MVO and a smaller AAR, % LV mass than normal weight patients among subjects undergoing pPCI for STEMI.
超重和肥胖患者在ST段抬高型心肌梗死(STEMI)后生存率更高,这一点已得到证实。本研究评估了STEMI后体重指数(BMI)、微血管阻塞(MVO)和梗死相关面积(AAR)之间的关联。
对因STEMI接受直接经皮冠状动脉介入治疗(pPCI)的患者进行前瞻性观察研究,并在5-7天内进行心脏磁共振成像。患者被分为正常体重(18.5≤BMI<24.0kg/m)、超重(24.0≤BMI<28.0kg/m)或肥胖(BMI≥28kg/m)。
在225例接受pPCI的患者中,67例(30.00%)为正常体重,113例(50.22%)为超重,45例(20.00%)为肥胖。多变量调整后,与正常BMI相比,BMI≥28kg/m与MVO风险降低显著相关(超重:HR 0.29,95%CI 0.13-0.68,p=0.004)。与正常体重患者相比,肥胖和超重患者的心脏往往更大(左心室舒张末期容积[LVEDV]和左心室[LV]质量更大)。在调整分析中,BMI升高与较小的AAR显著相关。此外,肥胖患者的AAR(β=-0.252,95%CI -20.298--3.244,p=0.007)和AAR占左心室质量的百分比(β=-0.331,95%CI -0.211--0.062,p<0.001)均低于正常体重患者。
在因STEMI接受pPCI的患者中,肥胖(BMI≥28kg/m)与MVO风险较低以及AAR、AAR占左心室质量的百分比低于正常体重患者独立相关。